What is Pulmonary Artery Catheter - Global Market?
The Pulmonary Artery Catheter, often referred to as a Swan-Ganz catheter, is a medical device that plays a crucial role in monitoring a patient's cardiovascular health. It is inserted into a pulmonary artery to measure pressures in the heart, providing valuable data that can guide treatment decisions. The global market for this device is substantial and continues to grow. In 2022, the market was valued at US$ 1181.3 million. By 2029, it is expected to reach US$ 1528 million, representing a compound annual growth rate (CAGR) of 3.7% from 2023 to 2029. The United States holds the largest share of this market, accounting for approximately 60% of the total. The leading manufacturer of Pulmonary Artery Catheters is Edwards Lifesciences Corporation, which holds about 30% of the market share.
Four-lumen Catheter, Five-lumen Catheter, Six-lumen Catheter, Others in the Pulmonary Artery Catheter - Global Market:
Pulmonary Artery Catheters come in various types, including Four-lumen Catheter, Five-lumen Catheter, Six-lumen Catheter, among others. Each type has its unique features and applications, making them suitable for different clinical scenarios. The Four-lumen Catheter, for instance, allows for simultaneous measurement of pressures in different heart chambers, while the Five-lumen Catheter adds the capability of infusing medications or fluids directly into the heart. The Six-lumen Catheter, on the other hand, offers even more versatility, with additional lumens for other uses such as blood sampling or delivery of pacing wires. Despite their differences, all these catheters serve the same fundamental purpose of providing critical data for patient management.
ICUs, Non-ICUs in the Pulmonary Artery Catheter - Global Market:
The use of Pulmonary Artery Catheters is not limited to Intensive Care Units (ICUs). They are also used in Non-ICU settings. In ICUs, these catheters are often used for patients with severe heart or lung diseases, where continuous monitoring of heart pressures can guide treatment and potentially save lives. In Non-ICU settings, Pulmonary Artery Catheters can be used in the management of patients with less critical conditions, but who still require close monitoring of their cardiovascular status. For instance, they may be used in patients undergoing major surgery, where sudden changes in heart function can occur.
Pulmonary Artery Catheter - Global Market Outlook:
In summary, the Pulmonary Artery Catheter market is a significant and growing sector of the global healthcare industry. With the United States leading the market and Edwards Lifesciences Corporation being the top manufacturer, the market is expected to reach US$ 1528 million by 2029. These catheters, available in various types, are used in both ICU and Non-ICU settings, providing critical data that can guide patient management and potentially save lives.
| Report Metric | Details |
| Report Name | Pulmonary Artery Catheter - Market |
| Forecasted market size in 2029 | US$ 1528 million |
| CAGR | 3.7% |
| Forecasted years | 2023 - 2029 |
| Global Pulmonary Artery Catheter market, by region: |
|
| Global Pulmonary Artery Catheter market, Segment by Type: |
|
| Global Pulmonary Artery Catheter market, by Application |
|
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
